Overview of Systematic Reviews and Meta-analyses on Systemic Adverse Events Associated With Intravitreal Anti–Vascular Endothelial Growth Factor Medication Use
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Ophthalmology"
DOI: 10.1001/jamaophthalmol.2018.0002
Abstract: Importance The systemic safety of intravitreal anti–vascular endothelial growth factor (anti-VEGF) medications is still a matter of debate. Objective This overview of systematic reviews evaluates systemic adverse events associated with intravitreal anti-VEGF treatments in patients… read more here.
Keywords: meta analyses; systemic adverse; risk; intravitreal anti ... See more keywords
Outcomes of patients with active diabetic macular edema at the time of cataract surgery managed with intravitreal anti-VEGF injections: Outcomes of cataract surgery in active DME patients.
Sign Up to like & getrecommendations! Published in 2021 at "American journal of ophthalmology"
DOI: 10.1016/j.ajo.2021.04.002
Abstract: PURPOSE To investigate the outcomes of cataract surgery in patients with active diabetic macular edema (DME) who are receiving active treatment with intravitreal anti-vascular endothelial growth factor (VEGF) injections in the perioperative period. DESIGN Retrospective… read more here.
Keywords: anti vegf; surgery; intravitreal anti; vegf injections ... See more keywords
Posterior Capsule Rupture during Cataract Surgery in Eyes Receiving Intravitreal anti-VEGF Injections
Sign Up to like & getrecommendations! Published in 2020 at "Current Eye Research"
DOI: 10.1080/02713683.2020.1795884
Abstract: ABSTRACT Purpose To examine the risk of posterior capsule rupture (PCR) during phacoemulsification cataract surgery in patients who received intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections prior to surgery. Methods A retrospective study was conducted… read more here.
Keywords: anti vegf; intravitreal anti; vegf; vegf injections ... See more keywords
The Impact of Laboratory Findings and Optical Coherence Tomography Biomarkers on Response to Intravitreal Anti-VEGF Treatment in Patients with Diabetic Macular Edema
Sign Up to like & getrecommendations! Published in 2022 at "Seminars in Ophthalmology"
DOI: 10.1080/08820538.2022.2069470
Abstract: ABSTRACT Purpose To investigate potential laboratory and imaging biomarkers as treatment response predictors to intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents in patients with diabetic macular edema (DME). Methods The study included 36 treatment naïve… read more here.
Keywords: response; anti vegf; absence; intravitreal anti ... See more keywords
Intravitreal Anti-Vascular Endothelial Growth Factor and Moxifloxacin for Treatment of Tubercular Choroidal Granuloma and Sub retinal Abscess.
Sign Up to like & getrecommendations! Published in 2023 at "Ocular immunology and inflammation"
DOI: 10.1080/09273948.2022.2159843
Abstract: PURPOSE To report the treatment response of a case of tubercular choroidal granuloma and subretinal abscess with intravitreal anti-vascular endothelial growth factor (anti-VEGF) and moxifloxacin. METHOD Retrospective interventional case report. RESULTS A 34-year-old man presented… read more here.
Keywords: choroidal; choroidal granuloma; tubercular choroidal; intravitreal anti ... See more keywords
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2019.1643838
Abstract: ABSTRACT Introduction: Intravitreal anti-VEGF is the most effective therapy for wet AMD, although systemic effects on the endothelium cannot be excluded. Areas covered: The purpose of this review was to evaluate risk of thromboembolic events… read more here.
Keywords: anti vegf; intravitreal anti; systemic thromboembolic; thromboembolic adverse ... See more keywords
Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research.
Sign Up to like & getrecommendations! Published in 2021 at "Expert opinion on drug safety"
DOI: 10.1080/14740338.2021.1957829
Abstract: INTRODUCTION It is generally acknowledged that the ocular safety profile of intravitreal anti-VEGF drugs is acceptable, while the burden of systemic safety of these intravitreal agents is still being debated. The evaluation of the systemic… read more here.
Keywords: anti vegf; real world; intravitreal anti; safety ... See more keywords
P0590ADVERSE RENAL OUTCOME FOLLOWING ADMINISTRATION OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS IN A SINGLE TERTIARY CENTRE IN MALAYSIA
Sign Up to like & getrecommendations! Published in 2020 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfaa142.p0590
Abstract: Intravenous (IV) anti-vascular endothelial growth factor(VEGF) is a potent anti-angiogenic factor for the treatment of solid tumours. While, intravitreal anti-VEGF injection is used in the treatment for macular and retinal diseases. The effects of IV… read more here.
Keywords: anti vegf; serum creatinine; treatment; intravitreal anti ... See more keywords
Review of Ophthalmic and Breastfeeding Medicine Evidence: Real and Theoretical Risks of Intravitreal Anti-VEGF Administration in Lactating Women.
Sign Up to like & getrecommendations! Published in 2020 at "Retina"
DOI: 10.1097/iae.0000000000002946
Abstract: IMPORTANCE There is limited research regarding the consequences of treating lactating mothers with intravitreal anti-VEGF agents. Balancing the need for vision-saving treatment, the benefits of breastfeeding, and the concern for affecting the newborn can present… read more here.
Keywords: medicine; intravitreal anti; review ophthalmic; anti vegf ... See more keywords
Efficacy and safety of intravitreal anti‐tumour necrosis factor drugs in adults with non‐infectious uveitis – a systematic review
Sign Up to like & getrecommendations! Published in 2018 at "Acta Ophthalmologica"
DOI: 10.1111/aos.13699
Abstract: Anti‐tumour necrosis factor (TNF) drugs have been extensively used in non‐infectious uveitis (NIU), when corticosteroids or conventional immunosuppressive drugs cannot adequately control inflammation or intolerable side‐effects occur. However, systemic anti‐TNF therapies are also associated with… read more here.
Keywords: intravitreal anti; systematic review; efficacy; anti tnf ... See more keywords
Healthcare expenditure of intravitreal anti‐vascular endothelial growth factor inhibitors compared with dexamethasone implant for diabetic macular oedema
Sign Up to like & getrecommendations! Published in 2022 at "Acta Ophthalmologica"
DOI: 10.1111/aos.15151
Abstract: The aim of this study was to estimate the 1‐year costs associated with treating diabetic macular oedema (DME) patients using current intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) biologics compared with the dexamethasone implant. read more here.
Keywords: macular oedema; endothelial growth; anti vascular; intravitreal anti ... See more keywords